Loss of smell from COVID-19 may increase dementia risk
Scientists from the University of Chicago found loss of smell from COVID-19 may create a future 'dementia wave’.
They reviewed studies about the effect of...
1 in 8 people with COVID-19 develop long COVID symptoms
Scientists from the University of Groningen found one in eight adults (12.7%) who are infected with SARS-CoV-2 experience long-term symptoms due to COVID-19.
The research...
Rapid rise in monkeypox spurs calls for better tests, more vaccine doses
With U.S. monkeypox cases going from zero to more than 6,000 in less than three months, researchers concerned about the pace of transmission are...
This diabetes drug may lower death risk in people with type 2 diabetes and...
Scientists from Boston Children’s Hospital found that sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients...
Widely used fever and pain drugs may increase your COVID-19 risk
In a recent from the University of Sydney, scientists found that some of the most common pain and fever medicines might increase vulnerability to...
Scientists find a drug combo may help treat COVID-19 effectively
In a recent study from UCL, researchers found new drug combinations with the potential to treat severe cases of COVID-19 infection at different stages...
These widely used drugs may halve death risk in ‘long COVID’
In a recent study from the University of Florida, scientists found that among patients hospitalized for COVID-19 who seemingly recovered, severe systemic inflammation during their hospitalization...
Common bowel disease drugs may prevent severe COVID-19
In a recent study from Cedars-Sinai, scientists found that medicine for inflammatory bowel disease may protect against severe COVID-19.
In the study, the team found...
People with young kids at home less likely to get severe COVID-19
Scientists from Kaiser Permanente found that adults with young kids at home may be less likely than others to develop severe COVID-19.
Children bring home...
New nasal spray reduces COVID-19 infection by 62%
Scientists from the Queen Mary University of London found that the pHOXWELL nasal spray can reduce infection with SARS-CoV-2—the virus that causes COVID-19—by 62%.
The...